Pages
Products
Human CD274(-)/PDCD1 Stable Cell Line

Human CD274(-)/PDCD1 Stable Cell Line

Cat.No. :  CSC-RO0670

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Cat. No. CSC-RO0670
Description This cell line is engineered to stably overexpress human PDCD1 in a human CD274 knockout cell line.
Gene PDCD1
Host Cell Species Homo sapiens (Human)
Stability Validated for at least 10 passages
Application

1. Studying the interactions between immune cells and cancer cells

2. Studying the mechanisms of resistance to immune checkpoint blockade

3. High-throughput screening

4. Drug target validation

Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Shipping Dry ice
Storage Liquid nitrogen
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Quick Inquiry

Background

Applications

Publications

Q & A

Customer Reviews

The PDCD1 gene encodes a protein known as Programmed Cell Death 1 (PD-1), which is a cell surface receptor belonging to the Ig superfamily. PD-1 is primarily expressed on the surface of T cells, B cells, and natural killer cells, and plays a critical role in regulating immune responses by inhibiting the activation of these cells. PD-1 functions by interacting with its ligands, PD-L1 and PD-L2, which are expressed on the surface of various cells, including antigen-presenting cells and cancer cells. The interaction between PD-1 and its ligands leads to the inhibition of T cell activation, proliferation, and cytokine production, thereby preventing the development of excessive immune responses and reducing the risk of autoimmune diseases. Abnormal expression or mutations in the PDCD1 gene can lead to immune disorders. For example, PD-1-/- mice have been shown to have enhanced immune responses and develop autoimmune diseases. Additionally, PD-1 has been found to play a role in the development of tumor immune evasion, and targeting PD-1 has become a promising strategy for cancer immunotherapy. In summary, the PDCD1 gene and its encoded protein, PD-1, are essential for maintaining immune homeostasis and regulating immune responses. Dysregulation of PD-1 expression or function can lead to immune disorders and tumor immune evasion. Further research into the role and regulation of the PDCD1 gene may contribute to the development of novel therapeutic strategies for the treatment of these conditions.
The Human CD274(-)/PDCD1 Stable Cell Line has found significant applications in various research fields, clinical trials, and translational studies. This cell line serves as an essential tool for studying the functions and mechanisms of CD274 and PDCD1, which are crucial proteins involved in immune regulation and tumor progression. In research settings, the Human CD274(-)/PDCD1 Stable Cell Line allows researchers to investigate the role of CD274 and PDCD1 in immune cell activation, apoptosis, and tumor growth. It provides a valuable model to study the effects of CD274 and PDCD1 inhibitors and to explore potential therapeutic strategies for cancer treatment. Clinical trials benefit greatly from the use of this cell line. It enables researchers to assess the efficacy and safety of new immunotherapies targeting CD274 and PDCD1. Translationally, the Human CD274(-)/PDCD1 Stable Cell Line aids in the translation of basic research findings into clinical practice. It helps in the identification of promising drug candidates and in the assessment of their therapeutic potential. Additionally, this cell line can be used to study the effects of CD274 and PDCD1 inhibitors on immune cell populations in vitro, providing valuable insights into their potential applications in immunomodulatory therapies. In conclusion, the Human CD274(-)/PDCD1 Stable Cell Line plays a significant role in advancing our understanding of CD274 and PDCD1 function and their potential as therapeutic targets. Its applications in research, clinical trials, and translational studies contribute to the development of novel treatments for various diseases, with a focus on improving patient outcomes.
Customer Q&As
What is the PDCD1 gene and its function?

A: The PDCD1 gene encodes for the PD-L1 (programmed death-like 1) protein, which is a member of the B7 family of immune-regulatory proteins. PD-L1 is expressed on the surface of various cell types, including tumor cells and activated immune cells. It functions as a ligand for the PD-1 (programmed death 1) receptor, which is expressed on activated T cells and NK cells. The interaction between PD-L1 and PD-1 plays a key role in regulating immune responses and can promote tolerance or immune evasion in certain cancers.

How does the PDCD1 gene contribute to immune evasion in cancer?

A: The PDCD1 gene contributes to immune evasion in cancer by enabling tumor cells to express high levels of PD-L1. This overexpression can lead to the inhibition of T cells and NK cells, preventing them from effectively attacking and destroying tumor cells. This immune evasion mechanism allows cancer cells to survive and proliferate, leading to tumor progression and metastasis.

Are there any therapeutic implications of targeting the PDCD1 gene?

A: Targeting the PDCD1 gene and its protein product has significant therapeutic implications for the treatment of various cancers. Immunotherapies that block the interaction between PD-L1 and PD-1, such as antibodies against PD-L1 or PD-1, can enhance T cell activity and restore immune surveillance against cancer cells. These therapies have shown promising results in the treatment of melanoma, lung cancer, and other malignancies.

How is the expression of the PDCD1 gene regulated in normal and cancerous cells?

A: The expression of the PDCD1 gene is regulated by various factors, including cytokines, growth factors, and oncogenic signaling. In normal cells, PD-L1 expression is typically low. However, in cancerous cells, PDCD1 can become overexpressed due to genetic alterations or epigenetic changes, leading to increased PD-L1 production and contributing to immune evasion.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Adaptability

The Human CD274(-)/PDCD1 Stable Cell Line demonstrates high adaptability, allowing for easy integration into various experimental setups and research protocols, making it a versatile tool for studying immune regulation and cancer immunotherapy.

Germany

04/02/2022

Technical documentation

Detailed technical documentation is provided with the Human CD274(-)/PDCD1 Stable Cell Line, including comprehensive information on cell line generation, characterization, and recommended culture conditions.

United Kingdom

03/23/2023

Portability

The Human CD274(-)/PDCD1 Stable Cell Line is designed to be portable and compatible with different laboratory environments, allowing researchers to easily transfer and establish the cell line in their own facilities without compromising its functionality or stability.

French

12/18/2023

Training provision

The provider offers excellent training and support to researchers working with the Human CD274(-)/PDCD1 Stable Cell Line, including guidance on cell culture techniques, experimental design, and data analysis. This ensures that researchers have the necessary skills and knowledge to effectively utilize the cell line in their research.

Canada

07/27/2020

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER